Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav in Glaucoma (Switching Study)
NCT00519753Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2007
- Primary completion
- Dec 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in primary open-angle glaucoma (POAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started Aug 2007; status: completed.
02
Drugs
travoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT00519753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519753.